Celadon To Delist From AIM After Director Resignations
Troubled British cannabis pharmaceutical company Celadon Pharmaceuticals PLC said Monday that it has agreed to go private by delisting its shares from the junior investment market of the London Stock Exchange,...To view the full article, register now.
Already a subscriber? Click here to view full article